NCT03082053View on ClinicalTrials.gov

A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 7, 2017

Study Completion Date

June 6, 2018

Conditions
Advanced or Metastatic Biliary Tract CancerAdvanced or Metastatic Solid Tumors
Interventions
DRUG

varlitinib

IMP

DRUG

capecitabine

Companion Medication

Trial Locations (1)

Unknown

ASLAN Selected sites, Tokyo

Sponsors
All Listed Sponsors
lead

ASLAN Pharmaceuticals

OTHER